Literature DB >> 7823062

Multiple sclerosis in island populations: prevalence in the Bailiwicks of Guernsey and Jersey.

G Sharpe1, S E Price, A Last, R J Thompson.   

Abstract

The aim of this study was to establish for the first time the prevalence of multiple sclerosis in the Bailiwicks of Guernsey and Jersey, as representing the most southerly part of the British Isles. All patients with multiple sclerosis in the Channel Islands resident on prevalence day were identified by contacting all medical practices, Multiple Sclerosis, and Action Research for Multiple Sclerosis societies by letter and visits. The crude overall prevalence rates were 113/100,000 (95% confidence interval (95% CI) 90.3-135.7) and 86.7/100,000 (95% CI 63.3-110.0) for the Bailiwicks of Jersey and Guernsey respectively. When standardised to the age and sex structure of a previously reported Northern Ireland population the standardised prevalence ratios were 120.2/100,000 (95% CI 96.0-144.3) for Jersey and 95.6/100,000 (95% CI 69.9-121.3) for the Bailiwick of Guernsey. When compared with recent studies in the northern United Kingdom the prevalence rates for multiple sclerosis in the Channel Islands lend some support to the proposed latitudinal gradient in the British Isles although the standardised prevalence ratio in the Bailiwick of Jersey is similar to those found in recent studies of southern Britain. The standardised prevalence rates of probable and definite multiple sclerosis for the male populations were 37.3/100,000 (95% CI 17.9-56.7) for the Bailiwick of Guernsey and 45.5/100,000 (95% CI 26.3-64.7) for the Bailiwick of Jersey whereas the standardised prevalence rates for the female populations were 97.5/100,000 (95% CI 73.9-143.5) and 139.5/100,000 (95% CI 112.6-181.2) respectively. Thus there is a striking and unexplained 43% higher prevalence of probable and definite multiple sclerosis in the female population of Jersey compared with that of the Bailiwick of Guernsey. This seems to be due to an unusually low prevalence of the disease among the female population of the Bailiwick of Guernsey compared with that of the United Kingdom mainland.

Entities:  

Mesh:

Year:  1995        PMID: 7823062      PMCID: PMC1073263          DOI: 10.1136/jnnp.58.1.22

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

1.  The prevalence of multiple sclerosis in the Southampton and South West Hampshire Health Authority.

Authors:  M H Roberts; J P Martin; D L McLellan; S A McIntosh-Michaelis; A J Spackman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

2.  Unusual occurrence on a tropical island of multiple sclerosis.

Authors:  W A Sheremata; D C Poskanzer; D G Withum; C L MacLeod; M E Whiteside
Journal:  Lancet       Date:  1985-09-14       Impact factor: 79.321

3.  Multiple sclerosis in Iceland: 1. Evidence of a postwar epidemic.

Authors:  J F Kurtzke; K R Gudmundsson; S Bergmann
Journal:  Neurology       Date:  1982-02       Impact factor: 9.910

4.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

5.  Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology.

Authors:  D C Poskanzer; L B Prenney; J L Sheridan; J Y Kondy
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

6.  Multiple sclerosis in southern Europe. I: Prevalence in Sicily in 1975.

Authors:  G Dean; G Grimaldi; R Kelly; L Karhausen
Journal:  J Epidemiol Community Health       Date:  1979-06       Impact factor: 3.710

7.  The etiology of multiple sclerosis: temporal-spatial clustering indicating two environmental exposures before onset.

Authors:  D C Poskanzer; A M Walker; L B Prenney; J L Sheridan
Journal:  Neurology       Date:  1981-06       Impact factor: 9.910

8.  Multiple sclerosis in the Cambridge health district of east Anglia.

Authors:  C J Mumford; M B Fraser; N W Wood; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

9.  Prevalence of multiple sclerosis in five rural Suffolk practices.

Authors:  M J Lockyer
Journal:  BMJ       Date:  1991-08-10

Review 10.  The dissemination of multiple sclerosis. The Langdon-Brown lecture 1989.

Authors:  D A Compston
Journal:  J R Coll Physicians Lond       Date:  1990-07
View more
  9 in total

1.  Multiple sclerosis in south Cambridgeshire: incidence and prevalence based on a district register.

Authors:  N Robertson; J Deans; M Fraser; D A Compston
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

2.  The prevalence of multiple sclerosis in the Leeds Health Authority.

Authors:  H L Ford; E Gerry; C M Airey; A Vail; M H Johnson; D R Williams
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-05       Impact factor: 10.154

3.  Surveying multiple sclerosis in the United Kingdom.

Authors:  N Robertson; A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

4.  The epidemiology of multiple sclerosis in Devon: a comparison of the new and old classification criteria.

Authors:  C M Fox; S Bensa; I Bray; J P Zajicek
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-01       Impact factor: 10.154

5.  Multiple sclerosis in the north Cambridgeshire districts of East Anglia.

Authors:  N Robertson; J Deans; M Fraser; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-07       Impact factor: 10.154

6.  Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity.

Authors:  C McGuigan; A McCarthy; C Quigley; L Bannan; S A Hawkins; M Hutchinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

7.  Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.

Authors:  Seyed Aidin Sajedi; Fahimeh Abdollahi
Journal:  BMC Neurol       Date:  2012-09-24       Impact factor: 2.474

8.  Multiple sclerosis in Northern Ireland: a historical and global perspective.

Authors:  G V McDonnell; S A Hawkins
Journal:  Ulster Med J       Date:  2000-11

Review 9.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Authors:  Elaine Kingwell; James J Marriott; Nathalie Jetté; Tamara Pringsheim; Naila Makhani; Sarah A Morrow; John D Fisk; Charity Evans; Sarah Gabrielle Béland; Sophie Kulaga; Jonathan Dykeman; Christina Wolfson; Marcus W Koch; Ruth Ann Marrie
Journal:  BMC Neurol       Date:  2013-09-26       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.